Tandon N - Search Results

1

Impact of completing chronic hepatitis C (CHC) treatment on post-therapy healthcare cost.

Tandon N, Balart LA, Laliberté F, Pilon D, Lefebvre P, Germain G, Prabhakar A. Tandon N, et al. J Med Econ. 2014 Dec;17(12):862-71. doi: 10.3111/13696998.2014.964720. Epub 2014 Oct 8. J Med Econ. 2014. PMID: 25215925 Free article.

2

Reply: Essential need for research in hepatitis C.

Tandon N, Balart LA, Laliberté F, Pilon D, Lefebvre P, Germain G, Prabhakar A. Tandon N, et al. J Med Econ. 2015;18(7):514-5. doi: 10.3111/13696998.2015.1017504. Epub 2015 Apr 24. J Med Econ. 2015. PMID: 25744591 Free article. No abstract available.

3

Predictors of high healthcare resource utilization and liver disease progression among patients with chronic hepatitis C.

LaMori J, Tandon N, Laliberté F, Germain G, Pilon D, Lefebvre P, Prabhakar A. LaMori J, et al. Among authors: tandon n. J Med Econ. 2016;19(4):364-73. doi: 10.3111/13696998.2015.1127252. Epub 2016 Jan 11. J Med Econ. 2016. PMID: 26624985 Free article.

4

Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression: A Matched-Cohort Study Using a US Commercial Claims Database.

Amos TB, Tandon N, Lefebvre P, Pilon D, Kamstra RL, Pivneva I, Greenberg PE. Amos TB, et al. Among authors: tandon n. J Clin Psychiatry. 2018 Mar/Apr;79(2):17m11725. doi: 10.4088/JCP.17m11725. J Clin Psychiatry. 2018. PMID: 29474009 Free article.

5

Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders using Medicaid benefits.

Joshi K, Lafeuille MH, Kamstra R, Tiggelaar S, Lefebvre P, Kim E, Yue Y, Tandon N. Joshi K, et al. Among authors: tandon n. J Comp Eff Res. 2018 Feb;7(2):121-133. doi: 10.2217/cer-2017-0043. Epub 2017 Aug 15. J Comp Eff Res. 2018. PMID: 28809128 Free article.

6

Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.

Pilon D, Tandon N, Lafeuille MH, Kamstra R, Emond B, Lefebvre P, Joshi K. Pilon D, et al. Among authors: tandon n. Clin Ther. 2017 Oct;39(10):1972-1985.e2. doi: 10.1016/j.clinthera.2017.08.008. Epub 2017 Sep 15. Clin Ther. 2017. PMID: 28919292 Free article.

7

Real-world outcomes post-transition to once-every-3-months paliperidone palmitate in patients with schizophrenia within US commercial plans.

Emond B, El Khoury AC, Patel C, Pilon D, Morrison L, Zhdanava M, Lefebvre P, Tandon N, Joshi K. Emond B, et al. Among authors: tandon n. Curr Med Res Opin. 2019 Mar;35(3):407-416. doi: 10.1080/03007995.2018.1560220. Epub 2019 Jan 5. Curr Med Res Opin. 2019. PMID: 30556739

8

Rapid Initiation of Antiretroviral Therapy Following Diagnosis of Human Immunodeficiency Virus Among Patients with Commercial Insurance Coverage.

Benson C, Emond B, Lefebvre P, Lafeuille MH, Côté-Sergent A, Tandon N, Chow W, Dunn K. Benson C, et al. Among authors: tandon n. J Manag Care Spec Pharm. 2020 Feb;26(2):129-141. doi: 10.18553/jmcp.2019.19175. Epub 2019 Nov 20. J Manag Care Spec Pharm. 2020. PMID: 31747358 Free PMC article.

Patients initiating ART > 60 days after HIV diagnosis were excluded (N = 2,608 [27.9%]), while 6,743 (72.1%) initiated ART 60 days after diagnosis and were analyzed; 18.3% and 81.7% were classified in the 7 days and 8-60 days cohorts, respectively. ...Emond, Lefebvre, L …

Patients initiating ART > 60 days after HIV diagnosis were excluded (N = 2,608 [27.9%]), while 6,743 (72.1%) initiated ART 60 days …

9

Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic.

Pilon D, Joshi K, Tandon N, Lafeuille MH, Kamstra RL, Emond B, Lefebvre P. Pilon D, et al. Among authors: tandon n. Patient Prefer Adherence. 2017 Mar 23;11:619-629. doi: 10.2147/PPA.S127623. eCollection 2017. Patient Prefer Adherence. 2017. PMID: 28356723 Free PMC article.

10

Baseline characteristics and treatment patterns of patients with schizophrenia initiated on once-every-three-months paliperidone palmitate in a real-world setting.

Joshi K, Lafeuille MH, Brown B, Wynant W, Emond B, Lefebvre P, Tandon N. Joshi K, et al. Among authors: tandon n. Curr Med Res Opin. 2017 Oct;33(10):1763-1772. doi: 10.1080/03007995.2017.1359516. Epub 2017 Aug 4. Curr Med Res Opin. 2017. PMID: 28741387

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,124 results

Search Page